Si-Bone (SIBN) Shares Outstanding (Diluted Average) (2020 - 2026)
Si-Bone (SIBN) recorded quarterly Shares Outstanding (Diluted Average) of $44.0 million in Q1 2026, up 2.33% quarter-over-quarter from $43.0 million in Q4 2025, and up 3.83% on a YoY basis from $42.3 million in Q1 2025.
Si-Bone (SIBN) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
Si-Bone's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $44.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 3.83% year-over-year to $44.0 million; the TTM figure through Mar 2026 stood at $44.0 million (up 3.83% YoY), while the FY2025 annual figure was $43.0 million, up 3.6% from the prior year.
- Shares Outstanding (Diluted Average) was $44.0 million for Q1 2026 at Si-Bone, up from $43.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $44.0 million in Q1 2026 to a low of $33.8 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $39.2 million across 5 years, with a median of $40.9 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) advanced 2.19% in 2022, then advanced 18.19% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $34.2 million in 2022, then increased by 12.35% to $38.4 million in 2023, then gained by 7.91% to $41.5 million in 2024, then gained by 3.6% to $43.0 million in 2025, then increased by 2.33% to $44.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $44.0 million (Q1 2026), $43.0 million (Q4 2025), and $43.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | 43.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.96 Mn |
| Dec 31, 2025 | 42.96 Mn |
| Sep 30, 2025 | 43.19 Mn |
| Jun 30, 2025 | 42.56 Mn |
| Mar 31, 2025 | 42.34 Mn |
| Dec 31, 2024 | 41.47 Mn |
| Sep 30, 2024 | 41.32 Mn |
| Jun 30, 2024 | 41.32 Mn |
| Mar 31, 2024 | 40.93 Mn |
| Dec 31, 2023 | 38.43 Mn |
| Sep 30, 2023 | 40.27 Mn |
| Jun 30, 2023 | 36.40 Mn |
| Mar 31, 2023 | 34.92 Mn |
| Dec 31, 2022 | 34.20 Mn |
| Sep 30, 2022 | 34.07 Mn |
| Jun 30, 2022 | 34.05 Mn |
| Mar 31, 2022 | 33.79 Mn |
| Dec 31, 2021 | 33.15 Mn |
| Sep 30, 2021 | 33.34 Mn |
| Jun 30, 2021 | 32.98 Mn |